Logo image of UMAC

UNUSUAL MACHINES INC /US (UMAC) Stock Fundamental Analysis

NYSEARCA:UMAC - NYSE Arca - US91532F1021 - Common Stock - Currency: USD

8.2  +0.61 (+8.04%)

After market: 8.25 +0.05 (+0.61%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to UMAC. UMAC was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. UMAC has a great financial health rating, but its profitability evaluates not so good. UMAC shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

UMAC had negative earnings in the past year.
In the past year UMAC has reported a negative cash flow from operations.
In the past 5 years UMAC always reported negative net income.
UMAC had a negative operating cash flow in each of the past 5 years.
UMAC Yearly Net Income VS EBIT VS OCF VS FCFUMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

UMAC has a Return On Assets of -197.57%. This is amonst the worse of the industry: UMAC underperforms 97.60% of its industry peers.
The Return On Equity of UMAC (-214.79%) is worse than 91.20% of its industry peers.
Industry RankSector Rank
ROA -197.57%
ROE -214.79%
ROIC N/A
ROA(3y)-130.57%
ROA(5y)-90.46%
ROE(3y)-141%
ROE(5y)-96.71%
ROIC(3y)N/A
ROIC(5y)N/A
UMAC Yearly ROA, ROE, ROICUMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

The Gross Margin of UMAC (26.31%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of UMAC has declined.
The Profit Margin and Operating Margin are not available for UMAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-34.75%
GM growth 5YN/A
UMAC Yearly Profit, Operating, Gross MarginsUMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

8

2. Health

2.1 Basic Checks

UMAC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UMAC has more shares outstanding
There is no outstanding debt for UMAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UMAC Yearly Shares OutstandingUMAC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
UMAC Yearly Total Debt VS Total AssetsUMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 77.55 indicates that UMAC is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 77.55, UMAC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
UMAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 77.55
ROIC/WACCN/A
WACC8.93%
UMAC Yearly LT Debt VS Equity VS FCFUMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 6.97 indicates that UMAC has no problem at all paying its short term obligations.
UMAC has a better Current ratio (6.97) than 85.60% of its industry peers.
A Quick Ratio of 5.81 indicates that UMAC has no problem at all paying its short term obligations.
UMAC has a better Quick ratio (5.81) than 85.60% of its industry peers.
Industry RankSector Rank
Current Ratio 6.97
Quick Ratio 5.81
UMAC Yearly Current Assets VS Current LiabilitesUMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for UMAC have decreased strongly by -950.80% in the last year.
Looking at the last year, UMAC shows a very strong growth in Revenue. The Revenue has grown by 1029.21%.
UMAC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 936.35% yearly.
EPS 1Y (TTM)-950.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.67%
Revenue 1Y (TTM)1029.21%
Revenue growth 3Y936.35%
Revenue growth 5YN/A
Sales Q2Q%229.94%

3.2 Future

Based on estimates for the next years, UMAC will show a very strong growth in Earnings Per Share. The EPS will grow by 25.05% on average per year.
Based on estimates for the next years, UMAC will show a very strong growth in Revenue. The Revenue will grow by 128.10% on average per year.
EPS Next Y14.89%
EPS Next 2Y25.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year120.7%
Revenue Next 2Y128.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
UMAC Yearly Revenue VS EstimatesUMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2024 2025 2026 10M 20M 30M
UMAC Yearly EPS VS EstimatesUMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

UMAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year UMAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UMAC Price Earnings VS Forward Price EarningsUMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UMAC Per share dataUMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as UMAC's earnings are expected to grow with 25.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.05%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UMAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UNUSUAL MACHINES INC /US

NYSEARCA:UMAC (6/26/2025, 8:04:00 PM)

After market: 8.25 +0.05 (+0.61%)

8.2

+0.61 (+8.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)N/A N/A
Inst Owners4.9%
Inst Owner Change238.86%
Ins Owners8.37%
Ins Owner Change13.89%
Market Cap203.61M
Analysts82.5
Price Target13.6 (65.85%)
Short Float %10.97%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-758.79%
Min EPS beat(2)-1446%
Max EPS beat(2)-71.57%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.14%
Min Revenue beat(2)-21.41%
Max Revenue beat(2)19.14%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.76%
PT rev (3m)-4.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)30%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)38.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)22.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 29.13
P/FCF N/A
P/OCF N/A
P/B 12.81
P/tB 32.39
EV/EBITDA N/A
EPS(TTM)-3.36
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.28
BVpS0.64
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -197.57%
ROE -214.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.31%
FCFM N/A
ROA(3y)-130.57%
ROA(5y)-90.46%
ROE(3y)-141%
ROE(5y)-96.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-34.75%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.97
Quick Ratio 5.81
Altman-Z 77.55
F-Score3
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)189.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-950.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.67%
EPS Next Y14.89%
EPS Next 2Y25.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1029.21%
Revenue growth 3Y936.35%
Revenue growth 5YN/A
Sales Q2Q%229.94%
Revenue Next Year120.7%
Revenue Next 2Y128.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-297.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-139.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.54%
OCF growth 3YN/A
OCF growth 5YN/A